Miguel Bronchud, a seasoned cancer clinician and researcher as well as the co-founder of Regenerative Medicine Solutions, posted on LinkedIn:
“Do viruses contribute to the development of cancer, making the case for enhanced preventive vaccination initiatives more compelling?
An insightful article appeared in The Independent (UK) by John (Eddie) La Marca and The Conversation alongside Sarah Diepstraten on Tuesday, November 10, 2026.
This piece is based on a publication in The Lancet authored by a group of scientists from the Walter and Eliza Hall Institute in Australia.
Australia has historically played a significant role in the advancement of medicine, although this is frequently underappreciated. One notable contribution was the identification of blood 'growth factors', which were given an enigmatic title in the 1960s due to the mystery surrounding their molecular structure at that time.
The Walter and Eliza Hall Institute (WEHI) is an esteemed research facility focused on cancer and leukemia located in Melbourne, Australia, which I was familiar with approximately four decades ago during my research in Manchester on recombinant human G-CSF (a growth factor first discovered in New York at the MSK) with professors Mike Dexter and Derek Crowther.
However, the origins really trace back to Australia with Professor Don Metcalf, who dedicated his entire professional life to WEHI.
He was a remarkably patient and humble individual who discovered Colony Stimulating Factors (CSFs), substances that enhance the production of white blood cells and have transformed cancer therapies and bone marrow transplants for more than 40 million individuals around the globe.
His role in the discovery of EPO was also significantly important.
Cancer is associated with 2.3 million new cases globally linked to infections. The majority of these cases can be attributed to just five pathogens: Helicobacter pylori (4%), human papillomavirus, or HPV (4%), hepatitis B (2%), Epstein-Barr virus (1%), and hepatitis C (below 1%). These pathogens are capable of causing more than 20 distinct types of cancer, including stomach, liver, blood, and cervical cancers.
In essence: Approximately 12% of all cancer cases around the world in 2024 were probably induced by infections, based on new findings from the World Health Organization (WHO).
This certainly represents an area where the incoming WHO Director can provide valuable input, not only in supplying vaccination products but also in managing logistics across different regions and, crucially, tackling both cultural and socioeconomic access challenges.
The research published in The Lancet Oncology examined the incidence and causes of various types of cancer, particularly focusing on the impact of infections.
Viruses can contribute to cancer development in three primary ways.
The first method involves disabling a cell's capacity for self-destruction (for instance, through the inactivation of the TP53 protein) or halting its division (for example, by inactivating the RB protein). Typically, a healthy cell would aim to undertake these processes when it becomes infected by a virus.
The second method by which a virus may induce cancer is by integrating its own DNA into the DNA of the host cell, inadvertently disrupting genes responsible for regulating cell death or division (similar to those mentioned above).


0 Comments